Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action

Eur Heart J. 2018 Aug 7;39(30):2793-2799. doi: 10.1093/eurheartj/ehx027.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis*
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy
  • Heart Failure / therapy*
  • Humans
  • Precision Medicine*
  • Transitional Care

Substances

  • Biomarkers